for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Forge Therapeutics Entered Into A Research Collaboration And Option Agreement With Hoffmann-La Roche

March 25 (Reuters) - Roche Holding AG:

* FORGE THERAPEUTICS, INC. - ENTERED INTO A RESEARCH COLLABORATION AND OPTION AGREEMENT WITH HOFFMANN-LA ROCHE LTD.

* FORGE THERAPEUTICS, INC. - ROCHE HAS AN EXCLUSIVE OPTION TO LICENSE FG-LPXC LUNG PROGRAM FROM FORGE

* FORGE THERAPEUTICS, INC. - ELIGIBLE TO RECEIVE UP TO $190.5 MILLION IN TOTAL PAYMENTS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up